immun stapl woe
progress rais estim tax
net dbt
myth buster big brand get
much shelf space on-line ye
mind import price
evolv retail backdrop
drive growth clearli higherfor everyon
cl becam hpc pg earlier week report tough
neg price organ sale miss vs gross margin
price despit inflat commod management note seek
balanc volum price vs prior period depend price surfac
seem logic howev clearli price mute whilst cost pressur acceler
point broader issu face compani space cost drive sale
growth increas price power current suffici off-set
thought price
develop market price pressur across hpc see report
margin retail manufactur seek right balanc slower growth
environ price na europ wors expect
inconsist recent trend latam big surpris
effort spur volum believ cl potenti went far promot brazil
volum dd price mexico price also declin expect price still
challeng develop market less year unfold cost save
key off-set expect immedi improv emerg market
see reason optim rais estim tax
management note us categori growth improv vs flat
apac europ also better retail de-stock remain headwind consumpt
improv us europ set stage better condit
expect management lower lt sale target better
reflect current categori growth cl outlook base categori
appear achiev low end though note gm expect seem
emb price normal categori like see risk
rais ep lower tax rate offset reduc
organ sale growth op incom overal cl result
clearli reflect challeng domin share capabl take
aggress action self-help see compani better equip
reiter buy po base price-to-earnings prior ep
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price
object basis/risk page
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
person household fabric pet nutrit
brand includ ajax fab softsoap palmol
mennen speed stick hill pet nutrit
colgate-palmol product market
cl heavi exposur develop market
command market share oral care posit
compani well outpac peer earn
cash flow result see cl one
attract long-term growth stori larg
impact result recent see subsid
expect growth acceler next
cl report organ sale growth vs ep vs
line cl expect flat ep growth region
organ sale vs north america vs flat estim
europ vs latin america vs asia pacif
vs africa/eurasia hill segment organ sale came
vs expect full year organ sale vs
line cl expect low single-digit growth ep vs
y/i line cl low single-digit guid
gross margin y/i vs price raw materi
pressur fulli off-set fund growth save sg
vs expect ebit margin vs
full year gross margin expect expand
came short year advertis spend
sale vs oper margin quarter
year
tabl provid detail cl outlook introduc today
exclud impact global growth restructur program
low singl digit mid-singl digit
base assum
result region
pleas see tabl detail segment
tabl cl y/i result commentari segment
widen brand leadership toothpast driven colgat total clean-in-between colgat optic white
beauti radiant colgat sensit smart white tom main rapid relief sensit toothpast
widen brand leadership manual toothbrush driven colgat total zone manual
volum growth driven brazil andean region partial off-set declin
mexico central america
toothpast market share gain mexico peru panama dominican republ paraguay
volum growth driven franc itali germani
toothpast market share gain germani itali netherland belgium austria
volum growth driven india partial off-set declin philippin greater china
toothpast market share gain philippin
volum growth russia sub-saharan africa region off-set declin
turkey north africa/middl east region
toothpast market share gain south africa turkey saudi arabia morocco kazakhstan
volum growth driven unit state australia off-set declin japan franc
tabl cl y/i result commentari segment
breakdown cl organ sale segment show price impair sale growth
north america europ latam compani overal
chart cl organ sale growth segment
sale
sale
sale
ni non-controlling interest
mo end decemb
sale
sale
sale
sale
depreci amort
ni attribut non-controlling inter
price object base forward price-to-earnings ep estim
premium large-cap stapl closer compani histor averag rel
market time cl gener best-in-class organ sale growth
demonstr abil manag difficult macro-economic/curr
environ recent result challeng expect organ sale growth
acceler number recent headwind eas sale comp easier growth
prospect improv emerg market given better macro condit currenc
headwind also eas
risk downsid increas price competit stronger us macro
volatil particularli emerg market
olivia tong cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
helen troy
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
